NEW YORK – Bluejay Diagnostics said this week that it had inked an agreement with Blood Centers of America that could expand sales of Bluejay's near-patient Symphony blood testing platform for triage and disease monitoring. Under the agreement, Bluejay becomes a strategic partner of BCA member organizations and BCA will refer strategic group purchasing organization partners and member blood centers to Bluejay, which gains access to BCA members and their networks. The deal also opens opportunities for the organizations to collaborate on clinical studies and applications for the Symphony platform in the blood supply industry. Financial and other terms of the deal were not disclosed.
Abbott this week declared a quarterly dividend of $.51 per share payable on May 15 to shareholders of record at the close of business on April 14.
Lunit, a South Korean company that makes artificial intelligence technology for cancer diagnostics and treatment, said this week that it has established a wholly owned subsidiary for the European market. With the new Lunit Europe Holdings, to be based in Amsterdam, the firm seeks to build up its salesforce on the continent as well as strengthen and expand partnerships with medical device manufacturers. Notably, Lunit, which went public last year, has a partnership with Guardant Health.
The Hurdle division of UK-based biotechnology company Chronomics said this week that it has formed a strategic partnership to integrate its remote diagnostic platform with the software-as-a-service diagnostic laboratory information system of CloudLIMS. This integration will allow reference and clinical diagnostic labs to manage lab data, automate workflows, and monitor compliance with key regulations like HIPAA, GDPR, and CLIA through a single interface, according to the companies.
Biosero and Analytik Jena announced a comarketing agreement for their lab automation technologies this week. Under the agreement, the firms will showcase the value of pairing instruments from Jena, Germany-based Analytik Jena — which include a PCR thermal cycler, a real-time PCR thermal cycler, and a liquid handling system — with San Diego-based Biosero's Green Button Go lab automation software.
Alercell, a molecular diagnostics company based in Bozeman, Montana, said this week that it is opening a UK subsidiary, Alercell UK, that will have its principal office in London, including an R&D facility for neuroscience research that is expected to be operational this summer. Alercell is also in the process of founding a French subsidiary, Alercell France, that will be based in Paris and offer the firm's cancer and leukemia diagnostic tests.
In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on 360Dx.